A new editorial paper was published in Oncotarget’s Volume 14 on June 12, 2023, entitled, “ERβ as a mediator of estrogen signaling in inflammatory breast cancer.”
Taysha suspends its lead gene therapy programme after FDA feedback – Pharmaceutical Technology
Astellas Gene Therapies, Taysha’s partner for developing TSHA-120, chose not to exercise its right to obtain an exclusive license to the drug. Image Credit: Yurchanka
September 20, 2023